FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Project for Futuristic Surgical Training Receives CHF 12 Million in Funding
Surgical training: "With the ‘PROFICIENCY’ project, we want to advance simulator-based continuing education in surgery," explains Prof. Bruno Schmied, M.D., Chief of Surgery at the Cantonal Hospital of St. Gallen.
Marquee Tech Founders & Investors Join Ultrahuman’s Series A
Ultrahuman, a leading metabolic fitness platform that uses glucose biomarkers to help people optimize their lifestyle.
BlueWind Medical Raises $64 Million
BlueWind Medical notes the funds to be used to support the ramp in their commercial footprint in anticipation of potential FDA marketing clearance for the RENOVA iStim implantable neuromodulation device.
CognitiveCare Receives a Grant of Nearly $1 Million to Advance Maternal and Fetal Health
CognitiveCare Inc. to provide antenatal risk stratification AI Support for the Bill & Melinda Gates Foundation-funded Antenatal Research Collaborative
Ictero Medical Closes $6M Series A Financing
Ictero Medical advises funding will be used to continue product development and complete initial clinical testing.
Ceryx Medical Raises £3.8m In Seed Funding
Funding will be used to commercialize its unique cardiology technology and commence the first-in-human clinical study of the Ceryx Medical innovative cardiac rhythm management device, Cysoni, later this year.
SoftBank Robotics Group Makes Strategic Equity Investment in Avalon SteriTech
SoftBank Robotics Group notes upon the completion of the transaction, SBRG will own approximately 5% stake in Avalon's disinfection business.
Blue Spark Technologies Raises $40 Million in Growth Funding
Blue Spark Technologies notes funding will go towards scaling the company’s sales and marketing functions and the continued advancement of Blue Spark’s wearable remote patient monitoring solutions.
David C Dvorak Invests $5 Million in THINK Surgical
David C Dvorak had a successful 16-year career at Zimmer Biomet Holdings, Inc. where he most recently held the position of president and chief executive officer for a decade.
Medical Device News Magazine
